AwardedAwarded 27 April 2026
CDMO for EMBED 3.0 Research Study
Cardiff University · Education
In brief
Cardiff University awarded research work to ProMed Pharma, LLC on 27 April 2026.
Built from the notice's own fields. Always check the official notice before you bid.
What the notice says
Due to the highly specific technical requirements regarding product manufacture (microinjection-moulding (MIM) of formulations containing API) it rapidly became clear that we needed to separate the production from the clinical trial services and identify separate vendors for these services. At the current stage of the program, the identification and selection of a Contract Development and Manufacturing Organization (CDMO) was prioritized by the EMBED team and the funder.
Who won
| Winner | Value | Dates |
|---|---|---|
| ProMed Pharma, LLC | $325,000 | Awarded 27 April 2026 |
Values as the award notice gives them, excluding VAT where stated.
Timeline
- Transparency notice · UK5, notice 037949-2026
- Contract award notice · UK6, notice 038100-2026
About the buyer
Cardiff UniversityLast 12 months
Procurements
91Awards
71Suppliers it has used most for research
- Celtic Terahertz Technology Limited1 contract
- ProMed Pharma, LLC1 contract
- Simbec-Orion Group Ltd1 contract
Similar open tenders
All open research tenders- £70kestimated
- £300kestimated
- £9,000estimated
- £38kestimated
- £260mframework ceiling
From notice 037949-2026 on Find a Tender, first published 27 April 2026, last updated 27 April 2026. We last checked for changes on 28 September 2026.